Criterion Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Criterion Capital Advisors's NVO Position: Q4 2024 in Review
Criterion Capital Advisors held its Novo Nordisk (NVO) position steady in Q4 2024 at 8,762 shares worth $1.25M. The position accounts for 0.79% of the portfolio, ranked #37.
Criterion Capital Advisors first reported a position in NVO in Q4 2023 and has held it in 5 quarters since. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.
- Criterion Capital Advisors held 8,762 shares of Novo Nordisk worth $1.25M as of Q4 2024.
- Criterion Capital Advisors left its Novo Nordisk share count unchanged in Q4 2024.
- Novo Nordisk made up 0.79% of Criterion Capital Advisors's portfolio in Q4 2024, its #37 holding.
- Criterion Capital Advisors first reported a position in Novo Nordisk in Q4 2023 and has held it in 5 quarters since.
- 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.
Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.